More

    Warning: Illegal string offset 'sidebar' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 498

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 498

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 500

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 504

    Warning: Illegal string offset 'sidebar' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 516

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 516

    Warning: Illegal string offset 'home' in /home/customer/www/stocks.com.au/public_html/wp-content/themes/mining/functions.php on line 518
    HomeHealth

    Health

    Calmer Co announces MetaSleep launch using Kavaton extract

    Health and wellness specialist The Calmer Co (ASX:CCO) announces US practitioner supplements brand Metagenics has launched MetaSleep: a new product that uses the company’s...

    Alterity Therapeutics pockets $1.3 million via tranche one placement

    Small-cap biotech Alterity Therapeutics (ASX:ATH) has pocketed $1.3 million from the first tranche of its $4.8 million share placement to help fund its ongoing...

    Botanix to raise $13.5 million for US Sofdra launch

    Clinical dermatology specialist Botanix Pharmaceuticals (ASX:BOT) is raising $13.5 million through a share placement to support the launch of its lead Sofdra product in...

    Chimeric Therapeutics posts ‘positive’ cell-killing data for cancer treatment

    It’s been a stellar day on the market for cell therapy specialist Chimeric Therapeutics (ASX:CHM) as the company posts ‘positive’ in vitro data for...

    Immutep gains insight into Germany trial

    Clinical-stage biotechnology company Immutep (ASX:IMM) has expanded its INSIGHT-003 trial to 4 sites across Germany, including the University Clinic of Ruhr Universitȁt Bochum and...

    Invex secures European patent for Exenatide

    Invex Therapeutics (ASX:IXC) has been granted a European patent for the use of Exenatide in Hydrocephalus, which is a neurological disorder associated with an...

    Invion steps closer to clinical trials for cancer treatment

    Life-science company Invion (ASX:IVX) has taken a ‘significant’ step towards starting clinical trials by reaching a manufacturing milestone for its INV043 drug substance, used...

    Austco wins $3.8 million for Singapore Health Campus

    Austco Healthcare (ASX:AHC) has been awarded a $3.8 million contract to refresh its Tacera Nurse Call platform for the Jurong Health Campus in Singapore.  The...

    Emyria receives approval for MDMA importation

    Emyria (ASX:EMD) has received approval from Health Canada to begin importating MDMA into Australia.  The $23.36 million market capitalisation company has received all necessary Health...

    IMEXHS locks in $1.6 million radiology services contract, Colombia

    IMEXHS (ASX:IME) subsidiary RIMAB has secured a $1.6 million radiology services contract with the San Carlos Hospital Foundation in the southern region of Bogota,...

    Imricor activates new site in Croatia

    Imricor Medical Systems (ASX:IMR) is activating a new invasive cardiovascular magnetic resonance (iCMR) imaging site in Zagreb, Croatia. The Clinical Hospital Dubrava has placed an...

    IMEXHS signs $2 million radiology services contract with Colombia National Police Force

    IMEXHS (ASX:IME) subsidiary RIMAB has secured a $2 million contract with Colombia’s National Police Force to provide radiology outsourcing services to 48,000 patients.  Under the...

    Cleo progresses development program for ovarian cancer test kit

    Ovarian cancer diagnostics company Cleo Diagnostics (ASX:COV) has finalised the selection of biomarkers to be used in its ovarian cancer test kit.  The $23.13 million...

    ECS Botanics and Medicann Health seal $24 million offtake agreement

    ECS Botanics (ASX:ECS) has secured a $24 million offtake agreement to supply medicinal cannabis dried flower over the next 5 years to Perth-based MediCann...

    Mach7 signs $15.26 million contract extension

    Mach7 Technologies (ASX:M7T) has extended a service and support agreement with the Hospital Authority of Hong Kong (HAHK) for 5 years to the value...

    Emyria secures MDMA supply for therapy trial

    Emyria (ASX:EMD) has secured the supply of locally-available MDMA — meaning it’s now set to being dosing for its MDMA-assisted therapy (MDMA-AT) trial for...

    AdAlta completes AD-214 study volunteer enrolment

    Clinical stage medicine developer AdAlta (ASX:1AD) has completed the enrolment of healthy volunteers into its AD-214 phase one extension study.  The $9.71 million market capitalisation...

    Hydralyte winds up $2.7 million entitlement offer

    The Hydration Pharmaceuticals Company (ASX:HPC), also known as Hydralyte North America, has completed an entitlement offer to raise $2.7 million for marketing and growth...

    BPH Global enters joint venture with Chemokine Yuesheng

    Biotechnology and pharmaceutical company BPH Global (ASX:BP8) has entered into a legally binding joint venture (JV) agreement with Singapore-based Chemokine Yuesheng to develop 2...

    InteliCare and JNC ink HoA

    Australian software company InteliCare (ASX:ICR) has executed a non-binding heads of agreement (HoA) with JNC Technologies Group to leverage its tech platform to JNC’s...